125
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Dissolution stability studies of suspensions of prolonged-release diclofenac microcapsules prepared by the Wurster process: I. Eudragit-based formulation and possible drug-excipient interaction

, , , , &
Pages 333-342 | Received 22 Jul 2004, Accepted 24 Sep 2004, Published online: 03 Oct 2008

References

  • Breikkreutz J. 2000. Leakage of enteric (Eudragit® L)-coated dosage forms in simulated gastric juice in the presence of poly(ethylene glycol). Journal of Control Release 67:79–88.
  • Fini A, Fazio G, Rabasco AM, Fernandez-hervas MJ, Holgado MA. 1999. Effect of temperature on a hydrate diclofenac salt. International Journal of Pharmaceutics 181:95–106.
  • Hancock C, York P, Rowe RC. 1997. The use of solubility parameters in pharmaceutical dosage form design. International Journal of Pharmaceutics 148:1–2.
  • Ichikawa H, Fukumori Y, Adeyeye CM. 1997. Design of prolonged release microcapsules containing diclofenac sodium for oral suspensions and their preparation by the Wurster process. International Journal of Pharmaceutics 156:39–48.
  • Jenquin MR, Liebowitz SM, Sarabia RE, McGinity JW. 1979. Physical and Chemical factors influencing the release of drugs from acrylic resin films. Journal of Pharmaceutical Sciences 811–816.
  • Khalil E, Sallam A. 1999. Interaction of two diclofenac acid salts with copolymers of ammoniomethacrylate: effect of additives and release profiles. Drug Developments in Industrial pharmaceutics 25:419–427.
  • Krajacid A, Tucker I.G. 2003. Matrix formation in sustained release tablets: possible mechanism of dose dumping. International Journal of Pharmaceutics 251:67–78.
  • Mathur AV, Hammonds KF, Klier J, Scranton AB. 1998. Equilibrium swelling of poly (methacrylic acid-ethylene glycol) hydrogels: effect of swelling medium and synthesis conditions. Journal of Controlled Release 54:177–184.
  • Technical Literature. 1999. Eudrgait R1 30D and RS 30D aqueous acrylic polymer dispersion: Application in the production of pharmaceutical preparations. Rohm Pharma HMBH Weiterstadt, Prospectus (Info RL/RSD–1/e).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.